1. Home
  2. COCH vs DRIO Comparison

COCH vs DRIO Comparison

Compare COCH & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

HOLD

Current Price

$0.70

Market Cap

53.4M

Sector

Finance

ML Signal

HOLD

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

N/A

Current Price

$6.75

Market Cap

52.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COCH
DRIO
Founded
1995
2011
Country
United States
United States
Employees
47
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.4M
52.8M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
COCH
DRIO
Price
$0.70
$6.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$6.00
$35.00
AVG Volume (30 Days)
783.4K
13.2K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1559.02
EPS
N/A
1.25
Revenue
N/A
$7,394,000.00
Revenue This Year
$1.58
$20.27
Revenue Next Year
N/A
$47.58
P/E Ratio
N/A
$5.44
Revenue Growth
N/A
43.02
52 Week Low
$0.36
$0.38
52 Week High
$1.89
$17.74

Technical Indicators

Market Signals
Indicator
COCH
DRIO
Relative Strength Index (RSI) 49.31 45.85
Support Level $0.64 $6.13
Resistance Level $0.74 $8.00
Average True Range (ATR) 0.08 0.52
MACD -0.00 0.01
Stochastic Oscillator 32.50 26.47

Price Performance

Historical Comparison
COCH
DRIO

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

Share on Social Networks: